Zimmer Biomet Holdings Inc. SF-Notes 2025(30/30)
- BID
99.303
- ASK
99.495
- 100,000 Nom.100,000 Nom.
- 07/27, 19:05:40 PM
Type of financial instrument
Corporate Bond
Sub-Type
Health Care
Yield
1.11
Yield spread Bundesanleihe
-1.7340
Tradable for private investors
Yes
Minimum amount tradeable unit
5,000.00
Maturity
04/09/2030
Interest Rate
0.93 %
Currency
Swiss Franc
Facts & figures
Price data
| TRADE PLATFORM | ||
| LAST PRICE / YIELD | 99.303 G / 1.11 | 0 Units |
| PRICE DETERMINATION TIME | 07/27/2026 / 07:05:40 PM | |
| DAILY VOLUME (NOMINAL) | 0 | |
| YIELD SPREAD | -1.7340 | |
| FIXINGPRICE | - | |
| DAILY HIGH / LOW | 99.35 | 98.91 |
| PREV. DAY'S PRICE | 99.014 | (07/24) |
| CHANGE DAY BEFORE | +0.29 | 0.29 % |
| 52 WEEK HIGH / LOW | (-) | (-) |
Master Data
| WKN | A4EGBZ |
| ISIN | CH1478430742 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Corporate Bond |
| SUB-TYPE | Health Care |
| ISSUER | Zimmer Biomet Holdings Inc. |
| S&P RATING | Please log in to view this field |
| (TRADING) SEGMENT / TICKS | -/ - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| INTEREST RATE | 0.93 % |
| INTEREST RUN FROM | 04/09/2025 |
| NEXT INTEREST PAYMENT | 04/09/2026 |
| UNIT INTEREST FROM NOMINAL AMMOUNT | 0.84 % |
| TRADING CURRENCY / NOTATION | Swiss Franc/ Percent |
| NOMINAL CURRENCY | Swiss Franc |
| SETTLEMENT CURRENCY | Euro |
| QUOTATION | Continuous trading |
| ISSUING VOLUME | 210.00 Mil. |
| MINIMUM AMOUNT TRADEABLE UNIT | 5,000.00 |
| SMALLEST TRADEABLE UNIT | 5,000.00 |
| MATURITY | 04/09/2030 |
| MARKET MAKER | - |
| STEP UP/ DOWN WHEN RATING CHANGES | No |
| STEP UP FIXED AT ISSUE | No |
| STEP DOWN FIXED AT ISSUE | No |
| BOND CALLABLE BY THE ISSUER | Yes |
| BOND IS SUBORDINATED | No |
Description
Callable bond. Local currency bond: CHF.
Tradability Information
Please log in to see the tradability information for this stock.Not registered yet? Create your free account here.
Company profile
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.